908 Devices Inc.
NASDAQ:MASS
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
1.88
12.41
|
| Price Target |
|
We'll email you a reminder when the closing price reaches USD.
Choose the stock you wish to monitor with a price alert.
|
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
|
Bank of America Corp
NYSE:BAC
|
US |
|
|
Mastercard Inc
NYSE:MA
|
US |
|
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
|
Pfizer Inc
NYSE:PFE
|
US |
|
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
|
Nike Inc
NYSE:NKE
|
US |
|
|
Visa Inc
NYSE:V
|
US |
|
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
|
3M Co
NYSE:MMM
|
US |
|
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
|
Coca-Cola Co
NYSE:KO
|
US |
|
|
Walmart Inc
NYSE:WMT
|
US |
|
|
Verizon Communications Inc
NYSE:VZ
|
US |
This alert will be permanently deleted.
908 Devices Inc.
Cash & Cash Equivalents
908 Devices Inc.
Cash & Cash Equivalents Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Cash & Cash Equivalents | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
9
|
908 Devices Inc.
NASDAQ:MASS
|
Cash & Cash Equivalents
$121m
|
CAGR 3-Years
-9%
|
CAGR 5-Years
76%
|
CAGR 10-Years
N/A
|
|
|
Teledyne Technologies Inc
NYSE:TDY
|
Cash & Cash Equivalents
$561m
|
CAGR 3-Years
1%
|
CAGR 5-Years
34%
|
CAGR 10-Years
16%
|
|
|
Keysight Technologies Inc
NYSE:KEYS
|
Cash & Cash Equivalents
$1.8B
|
CAGR 3-Years
-4%
|
CAGR 5-Years
2%
|
CAGR 10-Years
8%
|
|
|
Badger Meter Inc
NYSE:BMI
|
Cash & Cash Equivalents
$259m
|
CAGR 3-Years
57%
|
CAGR 5-Years
47%
|
CAGR 10-Years
38%
|
|
|
Trimble Inc
NASDAQ:TRMB
|
Cash & Cash Equivalents
$1B
|
CAGR 3-Years
26%
|
CAGR 5-Years
41%
|
CAGR 10-Years
22%
|
|
|
Zebra Technologies Corp
NASDAQ:ZBRA
|
Cash & Cash Equivalents
$676m
|
CAGR 3-Years
30%
|
CAGR 5-Years
83%
|
CAGR 10-Years
27%
|
|
908 Devices Inc.
Glance View
908 Devices, Inc. engages in the development of measurement devices for chemical and biochemical analysis. The company is headquartered in Boston, Massachusetts and currently employs 177 full-time employees. The company went IPO on 2020-12-18. The firm's Mass Spec devices are used at the point-of-need to interrogate unknown and invisible materials and provide answers to address problems in life sciences research, bioprocessing, industrial biotechnology, forensics and adjacent markets. Its products include MX908, Rebel and ZipChip. MX908 is a handheld Mass Spec device designed for analysis of gas, liquid and solid materials of unknown identity. MX908 is a multi-purpose device utilized by a spectrum of user segments for a variety of forensic field applications, including chemical, explosive, priority drug and hazardous materials operations, detecting materials at the trace level. The Rebel is a desktop analyzer providing real-time information on the extracellular environment in bioprocesses. ZipChip is a plug-and-play separation platform that optimizes Mass Spec sample analysis.
See Also
What is 908 Devices Inc.'s Cash & Cash Equivalents?
Cash & Cash Equivalents
121m
USD
Based on the financial report for Dec 31, 2023, 908 Devices Inc.'s Cash & Cash Equivalents amounts to 121m USD.
What is 908 Devices Inc.'s Cash & Cash Equivalents growth rate?
Cash & Cash Equivalents CAGR 5Y
76%
Over the last year, the Cash & Cash Equivalents growth was -36%. The average annual Cash & Cash Equivalents growth rates for 908 Devices Inc. have been -9% over the past three years , 76% over the past five years .
You don't have any saved screeners yet
